Belenos Biosciences Inc.
PrivateLast Round
VC Round
Jul 17, 2024
Est. Valuation
$68.58M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Belenos Biosciences Inc. operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a VC Round in July 2024.
Belenos Biosciences Inc. is a biotechnology company developing a pipeline of long-acting bispecific antibodies designed to transform the treatment of chronic inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Belenos Biosciences Inc. Comparables
Compare Belenos Biosciences Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Windward Bio | 81% | |
| Uniquity Bio | 80% | |
| Aclaris Therapeutics | 78% |
For institutional investors. Book with your work email.
Belenos Biosciences Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Belenos Biosciences Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 33% MoM.
- Aug 20, 2026
Grew 21% QoQ, from 14 to 17 employees.
For institutional investors. Book with your work email.
Belenos Biosciences Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Belenos Biosciences Inc.'s valuation, stock price, and market status.
Is Belenos Biosciences Inc. a public or private company?
Belenos Biosciences Inc. is a private company.
What is the current stock price of Belenos Biosciences Inc.?
Belenos Biosciences Inc. is a private company, so its shares have no public market price. Caplight tracks Belenos Biosciences Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Belenos Biosciences Inc. worth (valuation)?
Belenos Biosciences Inc.'s valuation is estimated at $68.6M based on funding round data.
Can I buy Belenos Biosciences Inc. stock?
Belenos Biosciences Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Belenos Biosciences Inc.'s last funding round?
Belenos Biosciences Inc.'s most recent funding round was VC Round on July 17, 2024.
Who are the main investors in Belenos Biosciences Inc.?
Key investors in Belenos Biosciences Inc. include OrbiMed.
Will Belenos Biosciences Inc. IPO soon?
No public IPO plans have been announced for Belenos Biosciences Inc..
How can I track Belenos Biosciences Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Belenos Biosciences Inc.'s shares on secondary markets.